Methotrexate is an active pharmaceutical ingredient (API) recognized as a folic acid antagonist. It can cause developmental toxicity according to an independent committee of scientific and health experts.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Restricted or banned substances
Substances on this list are banned or restricted under the named regulation. This page is a compliance reference — verify your obligations under applicable law.
CAS 59-05-2
Methotrexate 5-methyl ester
pharmaceutical intermediate
Ethopabate
pharmaceutical raw material
Nikethamide
pharmaceutical raw material
Phenylephrine
pharmaceutical raw material
Procaine
pharmaceutical raw material
Methotrexate sodium
pharmaceutical raw material
N-(4-{[(4-Amino-2-imino-2,3-dihydropteridin-6-yl)methyl][(²H₃)methyl]amino}benzoyl)glutamic acid
research compound
4-amino-4-deoxy-N10-methylpteroic acid
pharmaceutical intermediate
The international HS code for Methotrexate (CAS 59-05-2) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid
FBOZXECLQNJBKD-ZDUSSCGKSA-N
CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O